Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

A partial response in anaplastic carcinoma of the thyroid with liposomal doxorubicin.

Moscetti L, Padalino D, Capomolla E, Nelli F, Pollera CF.

J Exp Clin Cancer Res. 2005 Mar;24(1):151-4.

PMID:
15943045
2.

Remarkable response in 2 cases of Advanced Poorly Differentiated Thyroid Carcinoma with liposomal doxorubicin plus cisplatin.

Yang H, Chen Z, Wu M, Lei T, Yu H, Ge M.

Cancer Biol Ther. 2016 Jun 2;17(6):693-7. doi: 10.1080/15384047.2016.1167295.

3.

A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report.

Tanaka K, Sugitani I, Fujimoto Y.

Jpn J Clin Oncol. 2011 Sep;41(9):1074-8. doi: 10.1093/jjco/hyr095. Epub 2011 Jul 26.

PMID:
21791572
4.
5.

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

Shimaoka K, Schoenfeld DA, DeWys WD, Creech RH, DeConti R.

Cancer. 1985 Nov 1;56(9):2155-60.

6.

Adjunctive management of thyroid cancer: chemotherapy.

Shimaoka K.

J Surg Oncol. 1980;15(3):283-6.

PMID:
6159502
7.

Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma.

Skubitz KM.

Cancer Invest. 2003 Apr;21(2):167-76.

PMID:
12743981
8.

[Combined doxorubicin and bleomycin treatment of metastasising thyroid carcinoma: results in 21 patients (author's transl)].

Benker G, Hackenberg K, Hoff HG, Seeber S, Ebke J, Windeck R, Reinwein D.

Dtsch Med Wochenschr. 1977 Dec 30;102(52):1908-13. German.

PMID:
74313
9.

[Lymphangiosarcoma treated with liposomal doxorubicin (Caelyx)].

Verdier E, Carvalho P, Young P, Musette P, Courville P, Joly P.

Ann Dermatol Venereol. 2007 Oct;134(10 Pt 1):760-3. French.

PMID:
17978715
10.

Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.

Nachalon Y, Stern-Shavit S, Bachar G, Shvero J, Limon D, Popovtzer A.

JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1128-32. doi: 10.1001/jamaoto.2015.2332.

PMID:
26512447
11.

Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.

Behr TM, Wulst E, Radetzky S, Blumenthal RD, Dunn RM, Gratz S, Rave-Fränk M, Schmidberger H, Raue F, Becker W.

Cancer Res. 1997 Dec 1;57(23):5309-19.

12.

Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium.

Matuszczyk A, Petersenn S, Bockisch A, Gorges R, Sheu SY, Veit P, Mann K.

Horm Metab Res. 2008 Mar;40(3):210-3. doi: 10.1055/s-2008-1046781.

PMID:
18348081
13.

Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.

Vrbic S, Pejcic I, Vrbic M, Filipovic S.

J BUON. 2009 Jan-Mar;14(1):41-4.

PMID:
19373945
14.

[Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy].

Droz JP, Rougier P, Goddefroy V, Schlumberger M, Gardet P, Parmentier C.

Bull Cancer. 1984;71(3):195-9. French.

PMID:
6541515
15.

Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial.

Numico G, Castiglione F, Granetto C, Garrone O, Mariani G, Costanzo GD, Ciura PL, Gasco M, Ostellino O, Porcile G, Merlano M.

Lung Cancer. 2002 Jan;35(1):59-64.

PMID:
11750714
16.

Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.

Gottlieb JA, Hill CS Jr.

N Engl J Med. 1974 Jan 24;290(4):193-7. No abstract available.

PMID:
4808917
17.

Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma.

Bogner JR, Kronawitter U, Rolinski B, Truebenbach K, Goebel FD.

J Acquir Immune Defic Syndr. 1994 May;7(5):463-8.

PMID:
8158540
18.

Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.

Minisini AM, Andreetta C, Fasola G, Puglisi F.

Expert Rev Anticancer Ther. 2008 Mar;8(3):331-42. doi: 10.1586/14737140.8.3.331. Review.

PMID:
18366282
19.

Cytotoxic chemotherapy for differentiated thyroid carcinoma.

Sherman SI.

Clin Oncol (R Coll Radiol). 2010 Aug;22(6):464-8. doi: 10.1016/j.clon.2010.03.014. Epub 2010 May 8. Review.

PMID:
20452757
20.

Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.

Hantel C, Jung S, Mussack T, Reincke M, Beuschlein F.

Endocr Relat Cancer. 2014 Apr 28;21(3):383-94. doi: 10.1530/ERC-13-0439. Print 2014 Jun.

Supplemental Content

Support Center